Shares of Ocular Therapeutix Inc (NASDAQ:OCUL) have been assigned a consensus recommendation of “Buy” from the eight ratings firms that are currently covering the firm, Marketbeat.com reports. Seven analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. The average 12 month price objective among […]
